Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pectasides

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Critical Reviews in Oncology/Hematology|September 23, 2008
Current management of stage I testicular non-seminomatous germ cell tumoursD Pectasides, E Pectasides, A Constantinidou, et al.
Critical Reviews in Oncology/Hematology|December 3, 2008
Stage I testicular seminoma: management and controversiesD Pectasides, E Pectasides, A Constantinidou, et al.
Expert Opinion on Pharmacotherapy|May 26, 2006
Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?D Pectasides, A Psyrri, M Pectasides, et al.
Critical Reviews in Oncology/Hematology|June 24, 2010
Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literatureK Kamposioras, G Pentheroudakis, D Pectasides, et al.
American Journal of Clinical Oncology|April 1, 1992
Cerebrovascular accidents following hormonochemotherapy in cancer patientsD Pectasides, V Barbounis, A Athanassiou, et al.
The Pharmacogenomics Journal|January 18, 2012
Array-based pharmacogenomics of molecular-targeted therapies in oncologyD Sanoudou, G Mountzios, D A Arvanitis, et al.
Cancer|April 15, 1994
Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survivalS Retsas, M Quigley, D Pectasides, et al.
American Journal of Clinical Oncology|October 1, 1995
Chemotherapy for Merkel cell carcinoma with carboplatin and etoposideD Pectasides, G Moutzourides, M Dimitriadis, et al.
Anticancer Research|May 1, 2007
Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decadesA A Koumarianou, N Xiros, E Papageorgiou, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 17, 2004
Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancerI Kanakis, M Nikolaou, D Pectasides, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Critical Reviews in Oncology/Hematology|September 23, 2008
Current management of stage I testicular non-seminomatous germ cell tumoursD Pectasides, E Pectasides, A Constantinidou, et al.
Critical Reviews in Oncology/Hematology|December 3, 2008
Stage I testicular seminoma: management and controversiesD Pectasides, E Pectasides, A Constantinidou, et al.
Expert Opinion on Pharmacotherapy|May 26, 2006
Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?D Pectasides, A Psyrri, M Pectasides, et al.
Critical Reviews in Oncology/Hematology|June 24, 2010
Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literatureK Kamposioras, G Pentheroudakis, D Pectasides, et al.
American Journal of Clinical Oncology|April 1, 1992
Cerebrovascular accidents following hormonochemotherapy in cancer patientsD Pectasides, V Barbounis, A Athanassiou, et al.
The Pharmacogenomics Journal|January 18, 2012
Array-based pharmacogenomics of molecular-targeted therapies in oncologyD Sanoudou, G Mountzios, D A Arvanitis, et al.
Cancer|April 15, 1994
Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survivalS Retsas, M Quigley, D Pectasides, et al.
American Journal of Clinical Oncology|October 1, 1995
Chemotherapy for Merkel cell carcinoma with carboplatin and etoposideD Pectasides, G Moutzourides, M Dimitriadis, et al.
Anticancer Research|May 1, 2007
Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decadesA A Koumarianou, N Xiros, E Papageorgiou, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 17, 2004
Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancerI Kanakis, M Nikolaou, D Pectasides, et al.
Pageof 13